臨床試験機器・補助ソリューション市場：製品タイプ、フェーズ、エンドユース、適応症別-2024年～2030年の世界予測

臨床試験機器・補助ソリューション市場規模は2023年に42億1,000万米ドルと推計され、2024年には45億8,000万米ドルに達し、CAGR 8.81%で2030年には76億2,000万米ドルに達すると予測されています。

臨床試験機器・補助ソリューションは、治療法、薬剤、機器を正確かつ効果的に評価するために臨床試験中に使用される特殊な医療機器とサービスです。この機器には、患者モニター、画像システム、検査機器、自動データ収集システムなどが含まれます。また、臨床試験管理や薬事サポートなどの付帯サービスも含まれます。臨床試験機器・補助ソリューションは、参加者の安全性と試験結果の正確性を確保するために必要なツールやリソースを提供するため、臨床試験を成功させるために不可欠な要素です。臨床試験機器の補助的ソリューションには、臨床試験の完了を支援するために使用されるあらゆるツール、サービス、製品が含まれます。臨床試験機器および付帯ソリューションの研究開発活動への投資の増加は、技術革新を促進し、データ品質を向上させ、製品提供を拡大し、規制コンプライアンスを確保し、進化する臨床試験ニーズに対応し、新たな市場参入企業を惹きつけることによって、市場の成長を促進します。臨床試験業務のアウトソーシングは、費用対効果、専門知識へのアクセス、リーチの拡大、業務の合理化、法規制遵守、拡張性を提供し、臨床試験機器・補助ソリューションの利用をさらに増加させる。不正アクセスやデータ漏洩など、クラウドベースの臨床試験ソリューションに関連するデータセキュリティリスクは、機密性、規制遵守、データ整合性、サイバーセキュリティに対する懸念を生み、臨床試験機器・補助ソリューション市場の成長を妨げます。さらに、臨床試験機器に対する規制当局の承認が高まり、政府の支援により、試験活動の活発化、先端技術の採用、技術革新、規制プロセスの合理化が進み、予測期間における市場機会が創出されています。

製品機器リース＆レンタルサービスにおける付帯調達サービスの利用拡大

臨床試験において、付帯設備とは臨床試験のプロセス、オペレーション、システムに必要な特殊なツール、デバイス、器具を指します。補助器具は、医療スタッフが検査中のデータポイントを正確に測定できるようにすることで、臨床試験に不可欠な利点を提供します。臨床試験で使用されるラボ用機器には、遠心分離機、オートクレーブ、インキュベーター、極低温冷凍機、正確なサンプル分析に使用される分光光度計などがあります。画像診断機器には、X線装置、超音波装置、MRIスキャナー、CTスキャナー、スパイロメーター、臨床検査分析装置などが含まれます。臨床試験で使用される診断機器とは、試験中に参加者の健康状態を診断、評価、モニタリングするために使用される機器や装置を指します。

補助的調達サービスには、機器リース・レンタルサービス、調達、サプライ＆ロジスティクスが含まれます。サプライ＆ロジスティクスは、臨床試験機器・補助ソリューションプロバイダーが提供するサービスで、臨床試験の成功をサポートするために必要な資材の特定、評価、調達に重点を置く。サプライ＆ロジスティクスの付随的調達サービスは、臨床試験スポンサーが臨床試験に最適な付随的ソリューションを特定できるよう、市場調査と分析サポートを提供します。臨床試験におけるデータ管理・分析サービスは、臨床試験に関連するデータの収集、保管、分析を組織的に行います。臨床試験における保守・校正サービスは、達成された結果の安全性と正確性を確保するために不可欠であり、定期的な検査、保守、機器の校正を行う。臨床試験における規制・コンプライアンスサービスは、管理団体が定めた規則、規制、基準を確実に遵守するためのサービスおよびソリューションです。治験施設モニタリング＆サポートサービスとは、治験依頼者から治験施設に対して、治験プロセスを通じて継続的なサポート、モニタリング、監視を提供するサービスです。臨床試験におけるトレーニング＆コンサルティングサービスでは、ベストプラクティス、安全手順、規制遵守に関する事項について、研究スタッフや治験責任医師を教育します。さらに、臨床試験管理システムは、臨床試験ポートフォリオを効果的に計画、管理、追跡するために不可欠です。電子データ収集（EDC）システムは、臨床試験からのデータの収集、保存、確保を効率化するソフトウェアアプリケーションです。

タイプ生物学的製剤の製造プロセスにおける臨床試験機器の用途拡大

医療機器の臨床試験は、ヒトを対象とした疾患の治療、予防、診断に使用する医療機器の安全性や性能を評価するために実施される試験です。医療機器の臨床試験では、患者モニター、画像システム、診断ツール、データ管理システム、機器較正機器などの機器や付帯ソリューションが、正確な評価と試験の成功につながります。生物学的製剤の製造工程で使用される臨床試験用機器は、効率や精度の向上など多くのメリットをもたらします。生物学的製剤では、臨床試験機器はより質の高いデータ収集と分析をもたらし、医薬品製造の全体的な効率と精度を高めることができます。低分子の臨床試験で一般的に使用される機器には、高速液体クロマトグラフィー（HPLC）、超高速液体クロマトグラフィー（UHPLC）、ガスクロマトグラフィー（GC）、溶出試験装置、自動分注システム、遠心分離機などがあります。臨床試験分野で利用される補助的なソリューションには、サンプルの取り扱い、収集、保管、データ分析システム、患者記録のモニタリングと追跡のためのソフトウェアソリューション、サンプルの安全性とコンプライアンスが含まれます。

適応症消化器系疾患の分析における臨床試験機器への嗜好の高まり

臨床試験機器は、血液サンプル中の赤血球、白血球、ヘモグロビン、血小板を分析するためのコンピュータ化された高度に専門化された血液分析装置を提供することにより、血液疾患の臨床調査のワークフローを強化します。顕微鏡、胃カメラ、十二指腸内視鏡などの臨床試験用機器は、代謝性疾患や消化器系疾患の臨床試験において、臨床調査中の臨床結果を向上させるための分析に好まれています。急性骨髄性白血病、貧血性がん、慢性骨髄性白血病の病態を対象とした腫瘍学臨床試験用の機器や付帯ソリューションが利用可能です。心血管疾患、中枢神経系（CNS）および精神疾患、感染症、代謝性疾患の臨床試験では、臨床試験を効果的に実施するために、適応症に応じて医療用画像診断機器やスマートウェアラブルデバイスが採用されています。

フェーズ薬剤の有効性を評価するための第II相臨床試験における臨床試験機器と補助的ソリューションの利用拡大

第I相臨床試験は、主に新薬や治療薬の安全性と投与量の評価に重点を置いています。第I相臨床試験で使用される機器と補助的ソリューションには、投与量投与、患者モニタリング、安全性評価のためのツールが含まれます。開発プロセスの第I相では、薬物動態と忍容性の評価が100人以下の試験グループで行われ、これには健康なボランティアでの初回単回投与試験、用量漸増試験、反復投与試験が含まれます。第II相試験は、100人から500人という、より大規模な患者集団において、薬剤や治療法の有効性を評価するものです。この試験は、製品の予備的な有効性と副作用プロファイルを発見することを目的としています。第III相試験では、3,000人前後のより多くの患者集団を対象とし、新薬や治療法を既存の標準治療と比較します。第Ⅲ相試験は、薬剤の研究に長期間を要します。

最終用途：バイオテクノロジー・製薬企業における臨床試験機器の用途拡大

臨床試験機器および付帯ソリューションは、医薬品開発、開発業務受託機関（CRO）、製薬会社、バイオテクノロジー企業によって実施される臨床試験中の患者の進捗状況のモニタリングに利用されます。臨床試験機器および付帯ソリューションは、プロトコールの遵守を改善し、医療機器企業の規制基準への準拠を保証します。学術・研究機関は、臨床試験で最適なパフォーマンスを発揮するために、参加者やスタッフに教育的サポートを提供します。

地域別インサイト

南北アメリカの臨床試験機器・付帯ソリューション市場は、創薬開発に対する政府の支援投資やイニシアティブ、同地域における臨床試験活動の著しい成長により、非常に発展しています。アジア太平洋地域は、臨床試験を実施する上で大きなメリットとなる大規模で多様な患者基盤や低コストの要因によって、臨床試験機器・補助ソリューションの発展市場となっています。さらに、EMEA地域では、臨床試験機器・補助ソリューションの安全性と有効性を確保するための厳しい政府規範が、市場の競争と標準化を促進しています。欧州医薬品庁（EMA）、臨床試験規則536/2014（EU-CTR）、各地域の枠組みを含む様々な政府の枠組みが、同地域における臨床試験機器・補助ソリューションの使用を監視・規制しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは臨床試験機器・補助ソリューション市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、臨床試験機器・補助ソリューション市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.臨床試験機器・補助ソリューション市場の市場規模および予測は？

2.臨床試験機器・補助ソリューション市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.臨床試験機器・補助ソリューション市場の技術動向と規制枠組みは？

4.臨床試験機器・補助ソリューション市場における主要ベンダーの市場シェアは？

5.臨床試験機器・補助ソリューション市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 新薬や医療機器の安全かつ効果的な使用方法を決定する必要がある
    • 世界中で臨床試験活動のアウトソーシング
    • 臨床試験機器および補助ソリューションの研究開発活動への投資の増加
  • 抑制要因
    • クラウドベースの臨床試験ソリューションに関連するデータセキュリティリスク
  • 機会
    • 医薬品開発と臨床試験に対する政府の取り組みと支援
    • 臨床試験ソリューションにおける人工知能（AI）とデータ分析の統合
  • 課題
    • 臨床試験における国境を越えた物流手続きの複雑さ
• 市場セグメンテーション分析
  • 製品：機器リースおよびレンタルサービスにおける補助調達サービスの利用の増加
  • タイプ：生物学的医薬品の製造プロセスにおける臨床試験装置の適用拡大
  • 適応症：消化器疾患を分析するための臨床試験機器に対する需要の高まり
  • フェーズ：薬剤の有効性を評価するためのフェーズIIでの臨床試験機器と補助ソリューションの使用が増加
  • 最終用途：バイオテクノロジーおよび製薬企業における臨床試験機器の適用拡大
• 市場動向分析
  • 臨床試験の強化と満足のいく規制シナリオにより、アメリカでの市場成長が拡大
  • アジア太平洋地域での臨床試験数の増加と臨床試験機器・補助ソリューションの利用可能性の拡大
  • EMEA地域における政府の取り組みを奨励し、臨床試験と医薬品開発のインフラを前進させる
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 臨床試験機器・補助ソリューション市場：製品別

• 装置
• サービス
• システム

第7章 臨床試験機器・補助ソリューション市場：タイプ別

• 生物学的製剤
• 医療機器
• 小分子

第8章 臨床試験機器・補助ソリューション市場フェーズ別

• フェーズI
• フェーズII
• フェーズIII
• フェーズIV

第9章 臨床試験機器・補助ソリューション市場：最終用途別

• 学術調査機関
• バイオテクノロジーおよび製薬会社
• 契約調査機関
• 医療機器企業

第10章 臨床試験機器・補助ソリューション市場適応症別

• 血液疾患
• 心血管疾患
• 中枢神経系と精神障害
• 消化器疾患
• 免疫学
• 感染症
• 代謝障害
• 腫瘍学

第11章 南北アメリカの臨床試験機器・補助ソリューション市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の臨床試験機器・補助ソリューション市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの臨床試験機器・補助ソリューション市場

• デンマーク
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • RQM+がLibra Medicalを買収
  • Lambda TherapeuticsはMedidataと提携し、データ管理プロセスを自動化および合理化し、臨床試験の効率性を高めます。
  • MednetがiMednet eClinicalプラットフォーム内でDICOMイメージング機能を開始
  • Launch Therapeuticsが臨床試験開発を加速するためにMedidata AI Intelligent Trialsを選択
  • Clinical ink、新規患者の支払いと物流機能に関してMural Healthとの戦略的提携を発表
  • Cloudbyz、臨床調査を効率化し、新しい治療法の発売を加速する画期的な電子データキャプチャソリューションを発表
  • Clario、臨床試験向けクラウドベースの画像ビューアをリリース
  • ClinChoice、CRO買収で事業拡大を継続
  • Suvodaが専用ソフトウェアプラットフォームを発表
  • ヒューマ、臨床試験プラットフォーム拡大のためアルセディスを買収
  • CardieXの子会社ATCORがInvaryantと提携し、先進的なAI医療技術による臨床試験を実現
  • RQM+が臨床試験サービスを開始
  • エジソン・パートナーズが臨床試験情報破壊企業ロカバントへの2,100万米ドルの資金調達ラウンドを主導
  • パレクセル、中国蘇州に臨床試験用品および物流倉庫を開設
  • フィリップス、分散型臨床試験向け12誘導ECGソリューションを発表

第15章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET RESEARCH PROCESS
• FIGURE 2. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET DYNAMICS
• FIGURE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 16. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 20. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 25. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 26. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMAGING & DIAGNOSTIC EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMAGING & DIAGNOSTIC EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY LABORATORY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY LABORATORY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT LEASING & RENTAL SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT LEASING & RENTAL SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY & LOGISTICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY & LOGISTICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DATA MANAGEMENT & ANALYSIS SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DATA MANAGEMENT & ANALYSIS SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MAINTENANCE & CALIBRATION SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MAINTENANCE & CALIBRATION SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGULATORY & COMPLIANCE SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGULATORY & COMPLIANCE SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SITE MONITORING & SUPPORT SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SITE MONITORING & SUPPORT SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RANDOMIZATION & TRIAL SUPPLY MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RANDOMIZATION & TRIAL SUPPLY MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2024-2030 (USD MILLION)
• TABLE 67. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2023 (USD MILLION)
• TABLE 68. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2024-2030 (USD MILLION)
• TABLE 69. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 70. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 71. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 72. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 73. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 74. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 75. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 76. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 77. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 78. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 79. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 80. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 81. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 82. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 83. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 84. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 85. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 86. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 87. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 88. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 89. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 90. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 91. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 92. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 93. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 94. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 95. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 96. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 97. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 98. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 99. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 100. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 101. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 102. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 103. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2023 (USD MILLION)
• TABLE 104. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2024-2030 (USD MILLION)
• TABLE 105. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 106. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 107. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 108. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 109. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
• TABLE 110. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
• TABLE 111. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 112. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 113. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 114. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 115. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 116. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 117. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 118. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 119. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 120. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 121. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 122. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 123. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2023 (USD MILLION)
• TABLE 124. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2024-2030 (USD MILLION)
• TABLE 125. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 126. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 127. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 128. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 129. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
• TABLE 130. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
• TABLE 131. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 132. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 133. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 134. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 135. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 136. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 137. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 138. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 139. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 140. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 141. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2023 (USD MILLION)
• TABLE 142. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2024-2030 (USD MILLION)
• TABLE 143. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 144. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 145. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 146. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 147. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
• TABLE 148. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
• TABLE 149. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 150. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 151. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 152. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 153. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 154. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 155. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 156. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 157. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 158. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 159. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2023 (USD MILLION)
• TABLE 160. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2024-2030 (USD MILLION)
• TABLE 161. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 162. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 163. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 164. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 165. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
• TABLE 166. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
• TABLE 167. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 168. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 169. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 170. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 171. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 172. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 173. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 174. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 175. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 176. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 177. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2023 (USD MILLION)
• TABLE 178. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2024-2030 (USD MILLION)
• TABLE 179. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 180. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 181. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 182. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 183. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
• TABLE 184. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
• TABLE 185. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 186. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 187. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 188. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 189. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 190. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 191. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 192. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 193. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 194. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 195. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2023 (USD MILLION)
• TABLE 196. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2024-2030 (USD MILLION)
• TABLE 197. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 198. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 199. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 200. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 201. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
• TABLE 202. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
• TABLE 203. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 204. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 205. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 206. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 207. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 208. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 209. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 210. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 211. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 212. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 213. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 214. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 215. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2023 (USD MILLION)
• TABLE 216. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2024-2030 (USD MILLION)
• TABLE 217. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 218. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 219. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 220. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 221. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
• TABLE 222. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
• TABLE 223. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 224. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 225. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 226. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 227. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 228. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 229. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 230. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 231. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 232. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 233. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 234. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 235. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2023 (USD MILLION)
• TABLE 236. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2024-2030 (USD MILLION)
• TABLE 237. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 238. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 239. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 240. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 241. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
• TABLE 242. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
• TABLE 243. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 244. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 245. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 246. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 247. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 248. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 249. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 250. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 251. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
• TABLE 252. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
• TABLE 253. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2023 (USD MILLION)
• TABLE 254. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2024-2030 (USD MILLION)
• TABLE 255. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 256. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 257. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 258. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 259. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
• TABLE 260. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
• TABLE 261. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 262. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 263. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 264. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 265. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 266. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 267. INDIA CLINICAL

[189 Pages Report] The Clinical Trial Equipment & Ancillary Solutions Market size was estimated at USD 4.21 billion in 2023 and expected to reach USD 4.58 billion in 2024, at a CAGR 8.81% to reach USD 7.62 billion by 2030.

Clinical trial equipment & ancillary solutions are specialized medical equipment and services used during clinical trials to accurately and effectively evaluate treatments, drugs, and devices. This equipment includes patient monitors, imaging systems, laboratory instruments, and automated data collection systems. It also includes ancillary services such as clinical trial management and regulatory support. Clinical trial equipment & ancillary solutions are essential components of any successful clinical trial as they provide the necessary tools and resources to ensure participants' safety and the trial results' accuracy. An ancillary solution for clinical trial equipment includes any tools, services, or products used to assist in completing a clinical trial. Rising investment in R&D activities for clinical trial equipment and ancillary solutions drives market growth by fueling innovation, improving data quality, expanding product offerings, ensuring regulatory compliance, addressing evolving trial needs, and attracting new market participants. Outsourcing clinical trial activities provides cost-effectiveness, access to expertise, expanded reach, streamlined operations, regulatory compliance, and scalability, further increasing the use of clinical trial equipment & ancillary solutions. Data security risks associated with cloud-based clinical trial solutions, such as unauthorized access and data breaches, create concerns about confidentiality, regulatory compliance, data integrity, and cybersecurity, hampering the clinical trial equipment & ancillary solutions market growth. Moreover, rising regulatory approvals for clinical trial equipment and government support, which increased trial activity, adoption of advanced technologies, innovation, and streamlined regulatory processes, have created market opportunities in the forecasted period.

Product: Growing utilization of ancillary sourcing services for equipment leasing & rental services

In clinical trials, ancillary supplies equipment refers to the specialized tools, devices, and instruments necessary for the clinical trials processes, operations, or system. Ancillary supplies provide essential advantages to clinical trials by enabling medical staff to accurately measure data points during a test. Laboratory equipment used in clinical trials includes centrifuges, autoclaves, incubators, cryogenic freezers, and spectrophotometers used to ensure accurate sample analysis. Imaging & diagnostics equipment includes X-ray machines, sonography machines, MRI scanners, CT scanners, spirometers, and laboratory analyzers. Diagnostic equipment used in clinical trials refers to the instruments and devices employed to diagnose, assess, and monitor participants' health status during the test.

Ancillary sourcing services include equipment leasing & rental services, procurement, and supply & logistics, a service provided by clinical trial equipment and ancillary solutions providers that focuses on identifying, evaluating, and procuring the materials needed to support the success of a clinical trial. Supply & logistics ancillary sourcing services provide market research and analytical support to help clinical trial sponsors identify the optimal ancillary solutions for their trials. Data management & analysis services in clinical trials offer an organized way to collect, store, and analyze data related to the trial. Maintenance & calibration services in clinical trials are vital in ensuring the safety and accuracy of results achieved, which involve regular inspections, maintenance, and equipment calibration. Regulatory & compliance services in clinical trials are services and solutions that help ensure organizations comply with the rules, regulations, and standards established by a governing body. Site monitoring & support services in clinical trials involve providing ongoing support, monitoring, and oversight for research sites from the trial sponsor throughout the clinical trial process. Training & consulting services in clinical trials educate research staff and investigators on matters concerning best practices, safety procedures, and regulatory compliance. Moreover, a clinical trial management system is essential to effectively plan, manage, and track clinical study portfolios. An electronic data capture (EDC) system is a software application that helps streamline collecting, storing, and securing data from clinical studies.

Type: Increasing application of clinical trial equipment in the manufacturing process of biological drugs

Medical device clinical trials are examinations undertaken to assess a medical device's safety or performance in terms of its use in treating, preventing, or diagnosing diseases in human subjects. In medical device clinical trials, equipment and ancillary solutions such as patient monitors, imaging systems, diagnostic tools, data management systems, and device calibration equipment ensure accurate evaluation and successful trial outcomes. Clinical trial equipment used in the manufacturing process of biological drugs offers numerous benefits, including increased efficiency and accuracy. In biological drugs, clinical trial equipment results in higher-quality data collection and analysis, which can increase overall efficiency and accuracy in drug production. The commonly used equipment in small molecule clinical trials include high-performance liquid chromatography (HPLC), ultra-high performance liquid chromatography (UHPLC), gas chromatography (GC), dissolution testing apparatus, automated dispensing systems, and centrifuges. Ancillary solutions utilized in the clinical trials space include sample handling, collection, storage, data analysis systems, software solutions for monitoring and tracking patient records, and sample safety and compliance.

Indication: Rising preferences for clinical trial equipment to analyze digestive disorders

Clinical trial equipment enhances the workflow of clinical investigation of blood disorders by providing computerized, highly specialized hematology analyzers for analyzing red and white blood cells, hemoglobin, and blood platelets in a blood sample. Clinical trial equipment such as the microscope, gastroscope, and duodenoscope is preferred in analyzing metabolic disorders and digestive disorders clinical trials to enhance the clinical outcomes during clinical investigation. Equipment and ancillary solutions are available for acute myelogenous leukemia, anemic cancer, and chronic myeloid leukemia disease conditions for oncology clinical studies. Medical imaging equipment and smart wearable devices are employed in the clinical trials of cardiovascular diseases, central nervous system (CNS) & mental disorders, infectious diseases, and metabolic disorders depending upon the indication to organize clinical trials effectively.

Phase: Growing usage of clinical trial equipments & ancillary solutions in phase II to assess effectiveness of drug

Phase I clinical trials primarily focus on assessing the security and dosage of a new drug or treatment. Equipment and ancillary solutions used in phase I trials include tools for dose administration, patient monitoring, and safety assessments. During phase I of the development process, pharmacokinetics and tolerance evaluations occur in a trial group comprising 100 people or less, including initial single-dose studies, dose-escalation, and repeated-dose studies in healthy volunteers. Phase II trials assess the effectiveness of a drug or therapy in a larger group of patients, between 100 and 500. The trial aims to discover the product's preliminary efficacy and side effect profile. Phase III trials involve a larger patient population, around 3,000, and compare the new drug or treatment against existing standard therapies. Phase III trial takes an extended period to study the drug.

End-Use: Expanding application of clinical trial equipment in biotechnology & pharmaceutical companies

Clinical trial equipment and ancillary solutions are utilized in drug development, monitoring patient progress during a clinical trial executed by contract research organizations (CROs), pharmaceutical companies, and biotechnology companies. Clinical trial equipment and ancillary solutions improve protocol adherence and ensure compliance with medical device companies' regulatory standards. Academic & research institutes provide educational support to participants and staff for optimum performance in clinical trials.

Regional Insights

The clinical trials equipment & ancillary solutions market in the Americas is highly developing due to supportive governmental investments and initiatives for drug discovery and development and significant growth of clinical trial activities in the region. The Asia-Pacific region is an evolving market for clinical trial equipment & ancillary solutions owing to factors such as a large and diverse patient base and low costs that provide significant advantages for conducting clinical trials. Moreover, the stringent government norms in the EMEA region for ensuring the safety and efficacy of clinical trial equipment & ancillary solutions are making the market more competitive and standardized. The various government frameworks, including the European Medicines Agency (EMA), Clinical Trial Regulation 536/2014 (EU-CTR), and regional frameworks, monitor and regulate the use of clinical trial equipment & ancillary solutions in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Equipment & Ancillary Solutions Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Equipment & Ancillary Solutions Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Equipment & Ancillary Solutions Market, highlighting leading vendors and their innovative profiles. These include Almac Group Limited, Ancillare, LP, Avantor, Inc., Axelerist, B. Braun SE, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Dassault Systemes SE, Emsere B.V., Eppendorf SE, Eurofins Scientific SE, Global Vision Technologies, Inc., Hitachi, Ltd., IQVIA Holdings Inc., Lonza Group Ltd., MedNet Solutions, Inc., Myonex, Inc., Navitas Inc., Oracle Corporation, Parexel International Corporation, Quanticate International Limited, Quipment SAS, Royal Philips, Thermo Fisher Scientific, Inc., United Parcel Service, Inc., Veeva Systems Inc., Yokogawa Electric Corporation, and Zifo Technologies Private Limited.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Equipment & Ancillary Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Equipment
    • Imaging & Diagnostic Equipment
    • Laboratory Equipment

• Services
  • Ancillary Sourcing Services
    • Equipment Leasing & Rental Services
    • Procurement
    • Supply & Logistics

• Data Management & Analysis Services
• Maintenance & Calibration Services
• Regulatory & Compliance Services
• Site Monitoring & Support Services
• Training & Consulting Services

• Systems
  • Clinical Trial Management Systems
  • Electronic Data Capture Systems
  • Randomization & Trial Supply Management
• Type
  • Biologic Drugs
  • Medical Devices
  • Small Molecules

• Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

• End-Use
  • Academic & Research Institutes
  • Biotechnology & Pharmaceutical Companies
  • Contract Research Organizations
  • Medical Device Companies

• Indication
  • Blood Disorders
  • Cardiovascular Diseases
  • CNS & Mental Disorders
  • Digestive Disorders
  • Immunology
  • Infectious Diseases
  • Metabolic Disorders
  • Oncology

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Trial Equipment & Ancillary Solutions Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Equipment & Ancillary Solutions Market?

3. What are the technology trends and regulatory frameworks in the Clinical Trial Equipment & Ancillary Solutions Market?

4. What is the market share of the leading vendors in the Clinical Trial Equipment & Ancillary Solutions Market?

5. Which modes and strategic moves are suitable for entering the Clinical Trial Equipment & Ancillary Solutions Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Need to determine the safe and effective use of new drugs and medical device
    • 5.1.1.2. Outsourcing of clinical trial activity across the globe
    • 5.1.1.3. Increasing investment in R&D activities for clinical trials equipment & ancillary solutions
  • 5.1.2. Restraints
    • 5.1.2.1. Data security risks associated with cloud-based clinical trial solutions
  • 5.1.3. Opportunities
    • 5.1.3.1. Government initiatives and support for drug development and clinical trials
    • 5.1.3.2. Integration of artificial intelligence (AI) and data analytics in clinical trial solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities in procedures of cross border logistics for clinical trials
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing utilization of ancillary sourcing services for equipment leasing & rental services
  • 5.2.2. Type: Increasing application of clinical trial equipment in the manufacturing process of biological drugs
  • 5.2.3. Indication: Rising preferences for clinical trial equipment to analyze digestive disorders
  • 5.2.4. Phase: Growing usage of clinical trial equipments & ancillary solutions in phase II to assess effectiveness of drug
  • 5.2.5. End-Use: Expanding application of clinical trial equipment in biotechnology & pharmaceutical companies
• 5.3. Market Trend Analysis
  • 5.3.1. Augmenting clinical trials and satisfactory regulatory scenario enlarge the market growth in America
  • 5.3.2. Increasing number of clinical trials and the growing availability of clinical trial equipment & ancillary solutions in the Asia-Pacific region
  • 5.3.3. Advancing clinical trial and drug development infrastructure with encouraging government initiatives in the EMEA region
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis

6. Clinical Trial Equipment & Ancillary Solutions Market, by Product

• 6.1. Introduction
• 6.2. Equipment
• 6.3. Services
• 6.4. Systems

7. Clinical Trial Equipment & Ancillary Solutions Market, by Type

• 7.1. Introduction
• 7.2. Biologic Drugs
• 7.3. Medical Devices
• 7.4. Small Molecules

8. Clinical Trial Equipment & Ancillary Solutions Market, by Phase

• 8.1. Introduction
• 8.2. Phase I
• 8.3. Phase II
• 8.4. Phase III
• 8.5. Phase IV

9. Clinical Trial Equipment & Ancillary Solutions Market, by End-Use

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Biotechnology & Pharmaceutical Companies
• 9.4. Contract Research Organizations
• 9.5. Medical Device Companies

10. Clinical Trial Equipment & Ancillary Solutions Market, by Indication

• 10.1. Introduction
• 10.2. Blood Disorders
• 10.3. Cardiovascular Diseases
• 10.4. CNS & Mental Disorders
• 10.5. Digestive Disorders
• 10.6. Immunology
• 10.7. Infectious Diseases
• 10.8. Metabolic Disorders
• 10.9. Oncology

11. Americas Clinical Trial Equipment & Ancillary Solutions Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Finland
• 13.4. France
• 13.5. Germany
• 13.6. Israel
• 13.7. Italy
• 13.8. Netherlands
• 13.9. Norway
• 13.10. Poland
• 13.11. Qatar
• 13.12. Russia
• 13.13. Saudi Arabia
• 13.14. South Africa
• 13.15. Spain
• 13.16. Sweden
• 13.17. Switzerland
• 13.18. United Arab Emirates
• 13.19. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. RQM+ Acquires Libra Medical
  • 14.3.2. Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
  • 14.3.3. Mednet Launches DICOM Imaging Capabilities Within the iMednet eClinical Platform
  • 14.3.4. Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development
  • 14.3.5. Clinical ink Announces Strategic Partnership with Mural Health for New Patient Payment and Logistics Capabilities
  • 14.3.6. Cloudbyz Unveils Groundbreaking Electronic Data Capture Solution to Streamline Clinical Research and Accelerate Launch of New Therapies
  • 14.3.7. Clario Launches Cloud-Based Image Viewer for Clinical Trials
  • 14.3.8. ClinChoice continues expansion with CRO acquisition
  • 14.3.9. Suvoda launches purpose-built software platform
  • 14.3.10. Huma acquires Alcedis to expand clinical trial platform
  • 14.3.11. CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology
  • 14.3.12. RQM+ Launches Clinical Trial Services
  • 14.3.13. Edison Partners leads USD 21 million funding round for clinical trial intelligence disruptor Lokavant
  • 14.3.14. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
  • 14.3.15. Philips launches 12-lead ECG solution for decentralized clinical trials

15. Competitive Portfolio

• 15.1. Key Company Profiles
• 15.2. Key Product Portfolio